Up front allogeneic stem cell transplant is superior to tandem high-dose melphalan in cytogenetically defined ultra high-risk myeloma

Knop, S. and Liebisch, P. and Hebart, H. and Holler, E. and Engelhardt, M. and Bargou, R. C. and Metzner, B. and Doelken, G. and Peest, D. and Aulitzky, W. and Bunjes, D. and Straka, C. and Wandt, H. and Sezer, O. and Hentrich, M. and Ostermann, H. and Dechow, T. and Hess, G. and Hertenstein, B. and Freund, M. and Kropff, M. and Wolf, H. and Jung, W. and Frickhofen, N. and Maschmeyer, G. and Mergenthaler, H. and Kanz, L. and Meisner, C. and Einsele, H. (2011) Up front allogeneic stem cell transplant is superior to tandem high-dose melphalan in cytogenetically defined ultra high-risk myeloma. ONKOLOGIE, 34 (Suppl6). pp. 199-200. ISSN 0378-584X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 05 May 2020 05:50
Last Modified: 05 May 2020 05:50
URI: https://pred.uni-regensburg.de/id/eprint/20266

Actions (login required)

View Item View Item